Letters (Not) warts and all

All data on both vaccines must be considered

BMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a2554 (Published 19 November 2008) Cite this as: BMJ 2008;337:a2554
  1. Pim Kon, medical director1
  1. 1GlaxoSmithKline UK, Uxbridge UB11 1BT
  1. pim.7.kon{at}gsk.com

    The government chose the human papillomavirus (HPV) vaccine of GlaxoSmithKline (GSK), Cervarix, after considering protection against cancer causing HPV 16 and 18, HPV 6 and 11 (which cause genital warts), and HPV strains not included in the vaccine formulation; price; and supply.1

    Its decision was based on a comprehensive review of …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial